BEGIN:VCALENDAR
PRODID:-//Columba Systems Ltd//NONSGML CPNG/SpringViewer/ICal Output/3.3-
 M3//EN
VERSION:2.0
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
DTSTAMP:20240913T105052Z
DTSTART:20240924T130000Z
DTEND:20240924T140000Z
SUMMARY:Gateway to Translation: Lesson learned from AI-enabled RNA-small 
 molecule drug discovery
UID:{http://www.columbasystems.com/customers/uom/gpp/eventid/}kor-m10ll6b
 1-z3pmte
DESCRIPTION:Join us for our free online webinar\, as we hear from Dr Rabi
 a Khan on the topic of 'Lesson learned from AI-enabled RNA-small molecul
 e drug discovery'. \nSign-up online:  https://www.tickettailor.com/event
 s/g2tgatewaytotranslation/1369268\n\nThe “Gateway to Translation” (G2T) 
 webinar series is a joint initiative between the University of Cambridge
  (Cambridge Academy of Therapeutic Sciences\, CATS) and the University o
 f Manchester (Translation Manchester). These monthly webinars aim to sti
 mulate the translation of research into the clinics by educating academi
 cs about trends\, technologies and research in the commercial sphere and
  by facilitating collaborations between academia and the medtech\, biote
 ch and pharma industry sectors.  \nRecordings from previous webinars are
  available on the Translation Manchester and CATS websites.\nSeptember W
 ebinar\n \nThis month's webinar\, hosted by Cambridge Academy of Therape
 utic Sciences (CATS)\, will be on Tuesday 24th September from 2-3pm (via
  Zoom). Our guest speaker will be Dr Rabia Khan\, CEO of Serna Bio\, who
  will be giving a talk on the topic of “Mapping the Druggable Transcript
 ome: Lesson learned from AI-enabled RNA-small molecule drug discovery”\n
 Rabia Khan\, PhD\, MBA is the founder and CEO of Serna Bio\, a biotech b
 uilding the world's first map of the druggable transcriptome to address 
 novel inaccessible biology.\nBefore founding Serna Bio\, Dr. Khan was Ma
 naging Director of Discovery Sciences at Sensyne Health Plc (now: Arctur
 is) where she established the scientific strategy\, built the data scien
 ce and discovery teams and led the pharma partnerships with Bayer\, BMS\
 , Roche and Alexion and others. She has also held senior roles at Benevo
 lentAI and Meta (acquired by Chan Zuckerberg BioHub). \n\nTopic: “Mappin
 g the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small 
 molecule drug discovery”\nGuest Speaker: Dr Rabia Khan (Founder and CEO 
 of Serna Bio)\nDate and Time: Tuesday 24th September\, from 2-3pm (on Zo
 om)\nChaired by:  Prof Anne Willis\, OBE\, OMRC Investigator and the Dir
 ector of the MRC Toxicology Unit\nSign-up online:  https://www.tickettai
 lor.com/events/g2tgatewaytotranslation/1369268
STATUS:TENTATIVE
TRANSP:TRANSPARENT
CLASS:PUBLIC
LOCATION:Online (Zoom link in sign-up confirmation)
END:VEVENT
END:VCALENDAR